Mechanistically, TAF9 was shown to be deacetylated by HDAC1, which regulates the capacity of TAF9 to mediate fatty acid β-oxidation and LD accumulation during NAFLD. The gene discussed is TAF9; the disease is metabolic dysfunction-associated steatotic liver disease.